Showing results (91-100 of 206) with videos related to
Sort By:
Pageof 21
Archives of Environmental Health|July 1, 1981
Cadmium nephropathy: monitoring for early evidence of renal dysfunctionT Murray, B R Walker, D M Spratt, et al.Clinical Endocrinology|January 29, 2000
Endogenous inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 do not explain abnormal cortisol metabolism in polycystic ovary syndromeB R Walker, A Rodin, N F Taylor, et al.The American Journal of Physiology|August 11, 1989
Vasopressin-induced pulmonary vasodilation in ratsB R Walker, J Haynes, H L Wang, et al.The Journal of Steroid Biochemistry and Molecular Biology|April 1, 1993
Congenital and acquired syndromes of apparent mineralocorticoid excessC R Edwards, B R Walker, R Benediktsson, et al.The Journal of Clinical Investigation|December 1, 1970
Effects of increased sodium delivery on distal tubular sodium reabsorption with and without volume expansion in manV M Buckalew, B R Walker, J B Puschett, et al.Clinical Pharmacology and Therapeutics|May 1, 1984
Effect of renal impairment and hemodialysis on lorazepam kineticsG Morrison, S T Chiang, H H Koepke, et al.Clinical Endocrinology|November 26, 1998
Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patientsB R Walker, R Andrew, K M MacLeod, et al.The Journal of Clinical Endocrinology and Metabolism|September 16, 1999
Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductases, but not 11beta-hydroxysteroid dehydrogenasesM J Finken, R C Andrews, R Andrew, et al.Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology|June 1, 1982
Evidence for diminished sensitivity of the hamster pulmonary vasculature to hypoxiaB R Walker, N F Voelkel, I F McMurtry, et al.Clinical Therapeutics|January 1, 1981
Comparative antihypertensive effects of guanabenz and methyldopaB R Walker, M W Deitch, B E Schneider, et al.Pageof 21